NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV ...

Cidara’s lead candidate, CD388, is a long-acting antiviral prophylactic designed for universal prevention of seasonal and ...

Roche on Thursday launched direct-to-consumer U.S. sales of its influenza antiviral pill Xofluza at a discounted cash price ...

A new study of avian flu in cats focuses on a potentially life-saving discovery by veterinarian Dr. Jake Gomez, who treated ...

Learn flu symptoms, how it spreads, when you’re contagious, plus testing, antivirals and annual vaccines, including high-dose ...

Tue, Oct 21, 2025 One of the UK's most stunning national parks was under bird flu alert after more than 10,000 poultry face ...

A NEW ‘IDV’ flu variant detected in China has sparked pandemic fears, with experts fearing it may have developed the ability ...

The Food and Drug Administration has granted Breakthrough Therapy designation to CD388 for seasonal influenza prevention.

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the ...

The discounted access to Xofluza comes as the U.S. flu season begins. Genentech pointed to CDC data showing that last year’s ...

The New York City Health Department recommends that most people get the flu vaccine by the end of October each year, though people can continue to be vaccinated as long as the flu is circulating in ...